Skip to content

Home Treatment for Individuals Suffering From Severe Addictive Disorders

A Pilot Study on Home Treatment for Individuals Suffering From Severe Addictive Disorders

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05563363
Enrollment
40
Registered
2022-10-03
Start date
2022-12-01
Completion date
2026-05-31
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Brief summary

Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted. The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.

Interventions

OTHERHospital-like treatment in patients' home

Hospital-like treatment in patients' home. Caregivers, medical doctors and social workers will make several visits per day to the patients' home. 24/7 contact is available.

OTHERstandard inpatient treatment

Inpatient treatment on addiction ward

Sponsors

Louise Penzenstadler
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot study, randomized, open, non-blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Substance use disorder * age 18 or above * sufficient french language skills * competent subjects * consent to randomization progress

Exclusion criteria

* organic brain disease or developmental disorder * non voluntary admission * severe somatic comorbidity * History of complicated substance withdrawal * acute suicidal ideation * aggressive behavior * acute psychiatric disease such as mania or psychosis * distance to center (must be reachable within 60 minutes)

Design outcomes

Primary

MeasureTime frameDescription
readmission rates6 month post-dischargeNumber of readmissions to hospital during the 6 months following discharge

Secondary

MeasureTime frameDescription
time to readmission6 monthsNumber of days between discharge and readmission during the 6 months following discharge
length of hospitalization6 monthstotal number of days spent in hospital during the 6 months following discharge
number of emergency room visits6 monthsnumber of emergency room visits during the 6 months following discharge
clinical outcome6 monthsclinical outcomes measured with Health of the Nation Outcome scale (HoNOS) scoring 0 (no symptoms) to 48 (high symptom level) and the Brief Symptom Check-List (short form of the Brief Symptom Inventory), scoring 0-53 items (higher score = more symptoms). Measured at the start and end of intervention/hospital treatment.
patient satisfaction6 monthsPatient satisfaction measured with the S-ANQ (https://www.anq.ch/en/), a questionnaire used by all Swiss hospitals to measure patient satisfaction with treatment. The questionnaire includes 6 questions which are marked from 0 not at all satisfied to 5 = very satisfied. Scoring 0 (not at all satisfied) to 30 (very satisfied)

Countries

Switzerland

Contacts

Primary ContactLouise Penzenstadler, MD
Louise.E.Penzenstadler@hcuge.ch+41223725750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026